Pulmonary manifestations of liver diseases

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 1, 2009, Pages 60-69

  Yeshua, Hanny ^a   Blendis, Laurie M ^a   Oren, Ran ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hepatopulmonary syndrome; Liver diseases; Portopulmonary hypertension; Respiratory problems

Indexed keywords

AMILTRINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; INDOMETACIN; ISOSORBIDE 5 NITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORFLOXACIN; PENTOXIFYLLINE; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; SILDENAFIL; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; TERLIPRESSIN; UNCLASSIFIED DRUG; UNIPROST; VASODILATOR AGENT;

ARTERIAL GAS; ASCITES; ASTHMA; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; DISEASE SEVERITY; EVALUATION; GARLIC; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; HYPERTENSION; LIVER DISEASE; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG ANGIOGRAPHY; LUNG PERFUSION; MUSCLE ATROPHY; PATHOGENESIS; PATHOPHYSIOLOGY; PORTOPULMONARY HYPERTENSION; PROGNOSIS; RESPIRATORY TRACT DISEASE; REVIEW;

ANIMALS; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PULMONARY; LIVER DISEASES; LUNG DISEASES;

EID: 65349151879     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253209334615     Document Type: Review

References (95)

1. Rodríguez-Roisin R., Krowka MJ, Hervé P., Fallon MB: ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Eur Respir J. 2004 ; 24: 861-880.
2. Lange PA, Stoller JK The hepatopulmonary syndrome. Ann Intern Med. 1995 ; 122: 521-529.
3. Rodríguez-Roisin R., Krowka MJ Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med. 2008 ; 358: 2378-2387.
4. Gaines DI, Fallon MB Hepatopulmonary syndrome. Liver Int. 2004 ; 24: 397-401.
5. Schenk P., Fuhrmann V., Madl C., et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut. 2002 ; 51: 853-859.
6. Martínez GP, Barberà JA, Visa J., et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol. 2001 ; 34: 651-657.
7. Schenk P., Schöniger-Hekele M., Fuhrmann V., Madl C., Silberhumer G., Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003 ; 125: 1042-1052.
8. Teuber G., Teupe C., Dietrich CF, Caspary WF, Buhl R., Zeuzem S. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med. 2002 ; 13: 311-318.
9. Kaymakoglu S., Kahraman T., Kudat H., et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci. 2003 ; 48: 556-560.
10. Babbs C., Warnes TW, Haboubi NY Non-cirrhotic portal hypertension with hypoxaemia. Gut. 1988 ; 29: 129-131.
11. Regev A., Yeshurun M., Rodriguez M., et al. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat. 2001 ; 8: 83-86.
12. Fuhrmann V., Madl C., Mueller C., et al.. Hepatopulmonary syndromeinpatientswithhypoxichepatitis. Gastroenterology. 2006 ; 131: 69-75.
13. Krowka MJ, Wiseman GA, Burnett OL, et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO2 response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 ; 118: 615-624.
14. Crary GS, Burke BA, Alford BA, du Cret RP, Wood BP Radiological cases of the month. Pulmonary arteriovenous shunting in a child with cirrhosis of the liver. Am J Dis Child. 1989 ; 143: 749-751.
15. Rodríguez-Roisin R., Agustí AG, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax. 1992 ; 47: 897-902.
16. Rolla G., Brussino L., Colagrande P., et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med. 1998 ; 129: 375-378.
17. Cremona G., Higenbottam TW, Mayoral V., et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J. 1995 ; 8: 1883-1885.
18. Rolla G., Bucca C., Brussino L. Methylene blue in the hepatopulmonary syndrome. N Engl J Med. 1994 ; 331: 1098.
19. Schenk P., Madl C., Rezaie-Majd S., Lehr S., Müller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med. 2000 ; 133: 701-706.
20. Groneberg DA, Fischer A. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med. 2001 ; 135: 380-381.
21. Gómez FP, Barberà JA, Roca J., Burgos F., Gistau C., Rodríguez-Roisin R. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006 ; 43: 1084-1091.
22. Luo B., Abrams GA, Fallon MB Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol. 1998 ; 29: 571-578.
23. Zhang M., Luo B., Chen SJ, Abrams GA, Fallon MB Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol. 1999 ; 277 (5 Pt 1). G944 - G952.
24. Luo B., Liu L., Tang L., et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol. 2003 ; 38: 556-563.
25. Ling Y., Zhang J., Luo B., et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology. 2004 ; 39: 1593-1602.
26. Rabiller A., Nunes H., Lebrec D., et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med. 2002 ; 166: 514-517.
27. Zhang HY, Han de, W. Su, AR, et al. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors. World J Gastroenterol. 2007 ; 13: 6385-6395.
28. Sztrymf B., Rabiller A., Nunes H., et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J. 2004 ; 23: 752-758.
29. Gómez FP, Martínez-Pallí G., Barberà JA, Roca J., Navasa M., Rodríguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology. 2004 ; 40: 660-666.
30. Martinez G., Barberà JA, Navasa M., Roca J., Visa J., Rodriguez- Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol. 1999 ; 30: 882-889.
31. Molleston JP, Kaufman BA, Cohen A., et al. Brain abscess in hepatopulmonary syndrome. J Pediatr Gastroenterol Nutr. 1999 ; 29: 225-226.
32. Shijo H., Sasaki H., Nishimaru K., Okumura M. Recurrent intracranial hemorrhagic episodes in hepatopulmonary syndrome. Intern Med. 1992 ; 31: 786-790.
33. Martinez-Pallí G., Barberà JA, Taurà P., Cirera I., Visa J., Rodriguez-Roisin R. Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome. J Hepatol. 1999 ; 31: 1075-1079.
34. Aucejo F., Miller C., Vogt D., Eghtesad B., Nakagawa S., Stoller JK Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature. Liver Transpl. 2006 ; 12: 1278-1282.
35. Abrams GA, Sanders MK, Fallon MB Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl. 2002 ; 8: 391-396.
36. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology. 1995 ; 109: 1283-1288.
37. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 ; 114: 305-310.
38. Krowka MJ, Dickson ER, Cortese DA Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993 ; 104: 515-521.
39. Lee KN, Lee HJ, Shin WW, Webb WR Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature. Radiology. 1999 ; 211: 549-553.
40. Abrams GA, Fallon MB The hepatopulmonary syndrome. Clin Liver Dis. 1997 ; 1: 185-200, xiii.
41. Brussino L., Bucca C., Morello M., Scappaticci E., Mauro M., Rolla G. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet. 2003 ; 362: 43-44.
42. Abrams GA, Fallon MB Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol. 1998 ; 27: 232-235.
43. Añel RM, Sheagren JN Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis. 2001 ; 32: E131 - E136.
44. Tanikella R., Philips GM, Faulk DK, Kawut SM, Fallon MB Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl. 2008 ; 14: 1199-1203.
45. Selim KM, Akriviadis EA, Zuckerman E., Chen D., Reynolds TB Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol. 1998 ; 93: 455-458.
46. Martinez-Palli G., Drake BB, Garcia-Pagan JC, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2005 ; 11: 6858-6862.
47. De BK, Sen S., Biswas PK, et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology. 2002 ; 122: 897-903.
48. Poterucha JJ, Krowka MJ, Dickson ER, Cortese DA, Stanson AW, Krom RA Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology. 1995 ; 21: 96-100.
49. Taillé C., Cadranel J., Bellocq A., et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation. 2003 ; 75: 1482-1489.
50. Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D., Henderson JM Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med. 1995 ; 163: 133-138.
51. Swanson KL, Wiesner RH, Krowka MJ Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology. 2005 ; 41: 1122-1129.
52. Fallon MB, Krowka MJ, Brown RS, et al. Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 ; 135: 1168-1175.
53. Lange PA, Stoller JK The hepatopulmonary syndrome. Effect of liver transplantation. Clin Chest Med. 1996 ; 17: 115-123.
54. Philit F., Wiesendanger T., Gille D., Boillot O., Cordier JF Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration. 1997 ; 64: 173-175
55. Schiffer E., Majno P., Mentha G., et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant. 2006 ; 6: 1430-1437.
56. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003 ; 37: 192-197.
57. Collisson EA, Nourmand H., Fraiman MH, et al. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl. 2002 ; 8: 925-931.
58. Krowka MJ, Fallon MB Liver transplantation for hepatopulmonary syndrome (HPS): what is the MESSAGE ? Am J Transplant. 2008 ; 8: 911-912.
59. Budhiraja R., Hassoun PM Portopulmonary hypertension: a tale of two circulations. Chest. 2003 ; 123: 562-576.
60. Ramsay MA, Simpson BR, Nguyen AT, Ramsay KJ, East C., Klintmalm GB Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg. 1997 ; 3: 494-500.
61. Hervé P., Lebrec D., Brenot F., et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998 ; 11: 1153-1166.
62. Yoshida EM, Erb SR, Ostrow DN, Ricci DR, Scudamore CH, Fradet G. Pulmonary hypertension associated with primary biliary cirrhosis in the absence of portal hypertension: a case report. Gut. 1994 ; 35: 280-282.
63. Kawut SM, Krowka MJ, Trotter JF, et al. Pulmonary Vascular Complications of Liver Disease Study Group. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008 ; 48: 196-203.
64. Kawut SM, Taichman DB, Ahya VN, et al. Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl. 2005 ; 11: 1107-1111.
65. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006 ; 44: 1502-1510.
66. Swanson KL, Krowka MJ Arterial oxygenation associated with portopulmonary hypertension. Chest. 2002 ; 121: 1869-1875.
67. Ioachimescu OC, Mehta AC, Stoller JK Hepatopulmonary syndrome following portopulmonary hypertension. Eur Respir J. 2007 ; 29: 1277-1280.
68. Colle IO, Moreau R., Godinho E., et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003 ; 37: 401-409.
69. Castro M., Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996 ; 71: 543-551.
70. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008 ; 8: 2445-2453.
71. Krowka MJ, Swanson KL How should we treat portopulmonary hypertension ? Eur Respir J. 2006 ; 28: 466-467.
72. Krowka MJ Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 2006 ; 26: 265-272.
73. Krowka MJ, Frantz RP, McGoon MD, Severson C., Plevak DJ, Wiesner RH Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999 ; 30: 641-648.
74. Plotkin JS, Kuo PC, Rubin LJ, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation. 1998 ; 65: 457-459.
75. Fix OK, Bass NM, De Marco T., Merriman RB Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl. 2007 ; 13: 875-885.
76. Sussman N., Kaza V., Barshes N., et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant. 2006 ; 6: 2177-2182.
77. Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg. 1999 ; 5: 362-365.
78. Hoeper MM, Halank M., Marx C., et al. Bosentan therapy for portopulmonary hypertension. Eur Respir J. 2005 ; 25: 502-508.
79. Halank M., Kolditz M., Miehlke S., Schiemanck S., Schmeisser A., Hoeffken G. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wien Med Wochenschr. 2005 ; 155: 376-380.
80. Hoeper MM, Seyfarth HJ, Hoeffken G., et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J. 2007 ; 30: 1096-1102.
81. Makisalo H., Koivusalo A., Vakkuri A., Hockerstedt K. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl. 2004 ; 10: 945-950.
82. Chua R., Keogh A., Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant. 2005 ; 24: 498-500.
83. Callejas Rubio JL, Salmerón Escobar J., González- Calvín J., Ortego Centeno N. Successful treatment of severe portopulmonary hypertension in a patient with child C cirrhosis by sildenafil. Liver Transpl. 2006 ; 12: 690-691.
84. Reichenberger F., Voswinckel R., Steveling E., et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J. 2006 ; 28: 563-567.
85. Wang YW, Lin HC, Yang YY, Hou MC, Lee SD Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension. J Gastroenterol. 2006 ; 41: 593-597.
86. Bremer HC, Kreisel W., Roecker K., et al. Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report. J Med Case Reports. 2007 ; 1: 46.
87. Austin MJ, McDougall NI, Wendon JA, et al. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl. 2008 ; 14: 287-291.
88. Ribas J., Angrill J., Barberà JA, et al. Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension. Eur Respir J. 1999 ; 13: 210-212.
89. Kalambokis G., Korantzopoulos P., Nikas SA, Theodorou A., Tsianos EV Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment. J Hepatol. 2008 ; 48: 678-680.
90. Findlay JY, Harrison BA, Plevak DJ, Krowka MJ Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. Liver Transpl Surg. 1999 ; 5: 381-387.
91. Ramsay MA, Schmidt A., Hein HA, et al. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report. Hepatology. 1997 ; 25: 524-527.
92. Ashfaq M., Chinnakotla S., Rogers L., et al. The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant. 2007 ; 7: 1258-1264.
93. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004 ; 10: 174-182.
94. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000 ; 6: 443-450.
95. Swanson KL, Krowka MJ Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleve Clin J Med. 2008 ; 75: 121-122, 125-130, 133 passim.